Lineage Cell Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $101.7M
Liabilities Breakdown FY2018
Total Liabilities: $9.4M
Asset Breakdown
Total Assets: $101.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $23.6M | 23.2% |
| Accounts Receivable | $51.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.8M | 5.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $3.1M | 3.1% |
| Other Assets | $69.1M | 67.9% |
Liabilities Breakdown
Total Liabilities: $9.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.4M | 25.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $7.1M | 74.9% |